CoChat

Sequential presentation of primary biliary cirrhosis and autoimmune hepatitis

Efe, Cumali, Ozaslan, Ersan, Heurgué-Berlot, Alexandra, Kav, Taylan, Masi, Chiara, Purnak, Tugrul, Torgutalp, Murat, Muratori, Luigi, Bresson-Hadni, Solange, Thiéfin, Gérard, Schiano, Thomas D., Muratori, Paolo, Wahlin, Staffan · 2014 · European Journal of Gastroenterology & Hepatology

The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.

Abstract

BACKGROUND: Primary biliary cirrhosis (PBC)-autoimmune hepatitis (AIH) overlap syndrome is used to describe the coexistence of both diseases, with either a sequential or a simultaneous presentation in the same patient. Available studies have focused on the simultaneous form, whereas there is limited information on sequential PBC-AIH. We carried out a retrospective study of patients who sequentially developed PBC-AIH overlap syndrome. METHODS: The medical data of 1065 patients diagnosed with PBC (n=483) and AIH (n=582) were retrospectively analyzed. RESULTS: A sequential development of PBC-AIH was observed in 19 (1.8%) patients after a mean of 6.5 (1-14) years of follow-up. AIH developed in 12 (2.5%) PBC patients, whereas PBC occurred in seven (1.2%) patients with AIH. The baseline serologic and histological findings of patients who developed PBC-AIH were similar to those of patients with typical PBC or AIH. Eighteen patients were treated with a combination of ursodeoxycholic acid (UDCA) and immunosuppression after the diagnosis of PBC-AIH was established. One patient showed a spontaneous resolution of hepatitic flare under UDCA therapy. Biochemical remission was achieved in 16 patients, whereas three progressed to decompensated cirrhosis and required liver transplantation. CONCLUSION: The sequential overlap of PBC-AIH can occur during the follow-up of patients with pure PBC or AIH. In our cohort, we could not identify any factors that predicted the development of this rare condition. The combination of UDCA and immunosuppression seems to be an appropriate therapy in the setting of PBC-AIH.

Overview

Integrity signals

Registry

Crossref · 10.1097/meg.0000000000000075

Cites

42 of 42 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 42 references

Cited by

See all 34

Metadata

Authors
Efe, C., Ozaslan, E., Heurgué-Berlot, A., Kav, T., Masi, C., Purnak, T., Torgutalp, M., Muratori, L., Bresson-Hadni, S., Thiéfin, G., Schiano, T. D., Muratori, P., & Wahlin, S.
Affiliations
  • Mount Sinai Health System (US)
  • Hacettepe University (TR)
  • University of Bologna (IT)
  • Centre Hospitalier Universitaire de Reims (FR)
  • Mount Sinai Hospital (US)
Corresponding author
Efe, Cumali
Venue
European Journal of Gastroenterology & Hepatology
Published
2014-05
Volume
26
Issue
5
Pages
532-537
ISSN
0954-691X (ISSN-L)
OpenAlex
W2052576965
Cited by
32
References
42
Citations by year
2026: 4 · 2025: 3 · 2024: 1 · 2022: 2 · 2021: 3 · 2020: 7 · 2019: 1 · 2018: 3 · 2017: 2 · 2016: 3 · 2015: 3
FWCI
1.49
Type
journal article
Language
en
Open access
closed
Locations
  • European Journal of Gastroenterology & Hepatology (publishedVersion)
  • PubMed (publishedVersion)
  • HAL (submittedVersion)
  • Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna) (submittedVersion)
Funders
Alberta Innovates - Health Solutions
Topics
  • Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
  • Health Sciences › Medicine › Surgery › Pediatric Hepatobiliary Diseases and Treatments
  • Health Sciences › Medicine › Rheumatology › IgG4-Related and Inflammatory Diseases
Keywords
primary biliary cirrhosis, autoimmune hepatitis, PBC-AIH overlap syndrome, ursodeoxycholic acid, immunosuppression, biochemical remission, liver transplantation, decompensated cirrhosis
MeSH terms
Adolescent, Adult, Aged, Drug Therapy, Combination, Europe, Female, Gastrointestinal Agents, Humans, Immunosuppressive Agents, Liver, Liver Cirrhosis, Biliary, Male, Middle Aged, Remission Induction, Retrospective Studies, Risk Factors, Syndrome, Time Factors, United States, Ursodeoxycholic Acid, Biomarkers, Liver Transplantation, Treatment Outcome, Disease Progression, Hepatitis, Autoimmune, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Sequential presentation of primary biliary cirrhosis and autoimmune hepatitis. https://app.cochat.ai/papers/10.1097/meg.0000000000000075
The paper
Efe, C., Ozaslan, E., Heurgué-Berlot, A., Kav, T., Masi, C., Purnak, T., Torgutalp, M., Muratori, L., Bresson-Hadni, S., Thiéfin, G., Schiano, T. D., Muratori, P., & Wahlin, S. (2014). Sequential presentation of primary biliary cirrhosis and autoimmune hepatitis. European Journal of Gastroenterology & Hepatology. https://doi.org/10.1097/meg.0000000000000075

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.